000 | 01138 a2200325 4500 | ||
---|---|---|---|
005 | 20250512212907.0 | ||
264 | 0 | _c19830811 | |
008 | 198308s 0 0 eng d | ||
022 | _a0077-0094 | ||
024 | 7 |
_a10.1159/000407518 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStern, G M | |
245 | 0 | 0 |
_aClinical and pharmacological aspects of (-)-deprenyl treatment in Parkinson's disease. _h[electronic resource] |
260 |
_bModern problems of pharmacopsychiatry _c1983 |
||
300 |
_a215-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_aAmphetamine _xpharmacology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 |
_aPhenethylamines _xtherapeutic use |
650 | 0 | 4 |
_aSelegiline _xtherapeutic use |
700 | 1 | _aLees, A J | |
700 | 1 | _aHardie, R | |
700 | 1 | _aSandler, M | |
773 | 0 |
_tModern problems of pharmacopsychiatry _gvol. 19 _gp. 215-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000407518 _zAvailable from publisher's website |
999 |
_c6408295 _d6408295 |